INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 449s ago
HOUSE PTR29s ago
SEC 13F22s ago
ROBINHOOD CHAIN13s ago
Corporate insider
SN

Stagliano Nancy

DirectorCIK 0001817449

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells0 / 0
Max Insider Score9
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SN
Stagliano NancyDirector
ETRAElectra Therapeutics, Inc.
Derivative conversion
C—
255.6K sh
Sep 21, 2026Sep 21, 2026
traded Sep 21, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Electra Therapeutics, Inc.Director · Sep 21, 2026
9
SN
Stagliano NancyDirector
ETRAElectra Therapeutics, Inc.
Derivative conversion
C
—
255.6K sh
Sep 21, 2026
Sep 21, 2026
traded Sep 21, 2026
+0d
SEC FORM 4

Evidence